Tantraworasin Apichat, Saeteng Somcharoen, Siwachat Sophon, Jiarawasupornchai Tawatchai, Lertprasertsuke Nirush, Kongkarnka Sarawut, Ruengorn Chidchanok, Patumanond Jayanton, Taioli Emanuela, Flores Raja M
Department of Surgery, Faculty of Medicine, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
Department of Pathology, Faculty of Medicine, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
J Thorac Dis. 2017 Mar;9(3):666-674. doi: 10.21037/jtd.2017.02.90.
A surgical lung resection with systematic mediastinal lymph node (LN) dissection is recommended by the National Comprehensive Cancer Network guideline. However, the effective number of dissected LNs, stations and positivity is still controversial. The aim of this study is to identify the impact of total numbers, LN stations and positivity of dissected LNs on tumor recurrence and overall death in resectable non-small cell lung cancer (NSCLC).
This prognostic study used a retrospective data collection design. Adult patients with clinical resectable NSCLC who underwent pulmonary resection and mediastinal lymphadenectomy at Chiang Mai University between June 2000 and June 2012 were enrolled in this study. A multilevel mixed-effects parametric survival model was used to identify the effect of numbers, LN stations and positivity of dissected LNs to tumor recurrence and mortality.
The average number of dissected LNs was 22.7±12.8. Tumor recurrence was found in 51.3% and overall mortality was 43.3%. The number of dissected LNs was a prognostic factor for tumor recurrence [HR 0.98, 95% confidence interval (CI): 0.96-0.99]. There was a significant difference at the cut-pointed value of 11 dissected LNs for tumor recurrence (HR 2.22, 95% CI: 1.26-3.92). Dissection less than 11 nodes and less than 5 stations indicated a poor prognostic factor for tumor recurrence: for 3-4 stations (HR 3.01, 95% CI: 1.22-7.42) and for 1-2 stations (HR 1.96, 95% CI: 1.04-3.72). The positivity of dissected LNs was also a prognostic factor for tumor recurrence and overall mortality (HR 1.01, 95% CI: 1.01-1.02 and HR 1.01, 95% CI: 1.01-1.03, respectively).
Eleven or more LN dissection with at least 5 stations influenced recurrent-free survival. Systematic LN dissection (SLND) should be performed not only to identify the positivity of dissected LNs but also to determine an accurate tumor nodal stage. A larger cohort should be further conducted to support these findings.
美国国立综合癌症网络指南推荐对可手术的非小细胞肺癌(NSCLC)进行系统性纵隔淋巴结(LN)清扫的肺切除术。然而,清扫的LN有效数量、站别及阳性情况仍存在争议。本研究旨在确定清扫的LN总数、站别及阳性情况对可切除NSCLC患者肿瘤复发和总死亡的影响。
本预后研究采用回顾性数据收集设计。纳入2000年6月至2012年6月期间在清迈大学接受肺切除术和纵隔淋巴结清扫术的临床可切除NSCLC成年患者。采用多水平混合效应参数生存模型确定清扫的LN数量、站别及阳性情况对肿瘤复发和死亡率的影响。
清扫的LN平均数量为22.7±12.8。肿瘤复发率为51.3%,总死亡率为43.3%。清扫的LN数量是肿瘤复发的预后因素[风险比(HR)0.98,95%置信区间(CI):0.96 - 0.99]。在清扫11枚LN的截断值处,肿瘤复发存在显著差异(HR 2.22,95% CI:1.26 - 3.92)。清扫少于11枚淋巴结且少于5个站别提示肿瘤复发的预后不良因素:3 - 4个站别(HR 3.01,95% CI:1.22 - 7.42)和1 - 2个站别(HR 1.96,95% CI:1.04 - 3.72)。清扫的LN阳性情况也是肿瘤复发和总死亡的预后因素(分别为HR 1.01,95% CI:1.01 - 1.02和HR 1.01,95% CI:1.01 - 1.03)。
清扫11枚或更多LN且至少5个站别影响无复发生存。系统性LN清扫(SLND)不仅应进行以确定清扫的LN阳性情况,还应确定准确的肿瘤淋巴结分期。应进一步开展更大规模队列研究以支持这些发现。